Unravelling the Interplay between Cardiac Metabolism and Heart Regeneration

Fan Yu1,2,3, Shuo Cong1,2,3, En Ping Yap1,2,3

  • 1National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.

Insights

Heart regeneration is limited after ischemic heart disease (IHD) due to reduced cardiomyocyte proliferation. Targeting cardiac metabolism may offer new therapies for heart failure (HF) by promoting heart repair.

Area of Science:

  • Cardiovascular Research
  • Cellular Metabolism
  • Regenerative Medicine

Background:

  • Ischemic heart disease (IHD) is a primary cause of heart failure (HF), leading to significant global mortality.
  • Adult cardiomyocyte proliferation is limited, hindering the heart's natural repair capacity after ischemic events.
  • Metabolic substrate utilization shifts at birth correlate with reduced cardiomyocyte proliferation, suggesting a role for metabolism in cardiac regeneration.

Purpose of the Study:

  • To review the role of cardiac metabolism and mitochondria in heart regeneration.
  • To explore therapeutic strategies targeting the metabolism-proliferation axis for IHD and HF.
  • To identify potential targets for promoting cardiomyocyte cell cycle re-entry.

Main Methods:

  • Literature review on cardiac metabolism, mitochondria, and cardiomyocyte proliferation.
  • Analysis of the interplay between metabolic changes and regenerative capacity.
  • Discussion of therapeutic targets for heart repair.

Main Results:

  • Cardiac metabolism significantly influences cardiomyocyte proliferation and heart regeneration.
  • Mitochondria play a crucial role in regulating metabolic pathways essential for repair.
  • Modulating the metabolism-proliferation axis presents a promising therapeutic avenue.

Conclusions:

  • Understanding the link between cardiac metabolism and regeneration is key to developing novel therapies for IHD and HF.
  • Targeting metabolic pathways could enhance the heart's ability to regenerate after injury.
  • Further research into cardiomyocyte cell cycle regulation offers hope for reducing HF incidence.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
710
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
3.0K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
905